Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Era of the FLips: How Spike Mutations L455F and F456L (and A475V) Are Shaping SARS-CoV-2 Evolution
Daniele Focosi, Pietro Giorgio Spezia, Federico Gueli, et al.
Viruses (2023) Vol. 16, Iss. 1, pp. 3-3
Open Access | Times Cited: 17

Showing 17 citing articles:

Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants
Daniele Focosi, Arturo Casadevall, Massimo Franchini, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 217-217
Open Access | Times Cited: 12
Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data
Brian Lee, Ahmed Abdul Quadeer, Muhammad S. Sohail, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages
H. J. Yang, Xuemei He, Shi H, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Another variant another history: description of the SARS-CoV-2 KP.2 (JN.1.11.1.2) mutations
Francesco Branda, Alessandra Ciccozzi, Chiara Romano, et al.
Infectious Diseases (2024) Vol. 56, Iss. 7, pp. 581-585
Closed Access | Times Cited: 3
Features of the SARS-CoV-2 KP.3 variant mutations
Francesco Branda, Massimo Ciccozzi, Fabio Scarpa
Infectious Diseases (2024) Vol. 56, Iss. 10, pp. 894-896
Closed Access | Times Cited: 3
Subsequent Waves of Convergent Evolution in SARS-CoV-2 Genes and Proteins
Daniele Focosi, Pietro Giorgio Spezia, Fabrizio Maggi
Vaccines (2024) Vol. 12, Iss. 8, pp. 887-887
Open Access | Times Cited: 3
On the new SARS-CoV-2 variant KP.3.1.1: focus on its genetic potential
Francesco Branda, Massimo Ciccozzi, Fabio Scarpa
Infectious Diseases (2024) Vol. 56, Iss. 10, pp. 903-906
Closed Access | Times Cited: 3
Molecular epidemiology and population immunity of SARS-CoV-2 in Guangdong (2022–2023) following a pivotal shift in the pandemic
Zhencui Li, Pei Hu, Qu Lin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
What We Know about HV.1 (EG.5.1.6.1) SARS-CoV-2 Variant
Oscar M. Cóbar, Stella Cóbar
Medical Research Archives (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 1
Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants
Hisano Yajima, Tomo Nomai, Kaho Okumura, et al.
mBio (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 1
Partial N-gene target failure in the Seegene Allplex SARS-CoV-2 Master Assay as a proxy of SARS-CoV-2 BA.2.86
Maria Beatrice Valli, Maria Letizia Schiavone, Martina Rueca, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 6
Open Access
Genomic epidemiology and phylogeographic dynamics of SARS-CoV-2 during the sixth wave and post-sixth wave in Pakistan
Zunera Jamal, Syed Adnan Haider, Muhammad Ammar, et al.
Future Virology (2024) Vol. 19, Iss. 6-7, pp. 249-261
Closed Access
In Silico Evaluation of Ten Monoclonal Antibodies Neutralization Power of SARS-CoV-2 Variants EG.5, BA.2.86 and JN.1
Dana Ashoor
(2024)
Open Access
SARS-CoV-2 JN.1 variant: a short review
Sarkar Malay, Irappa Madabhavi, Anurag Tripathi
Monaldi Archives for Chest Disease (2024)
Open Access
Dynamics of SARS-CoV-2 variants during the XBB wave in the Republic of Korea
Jin Sun No, Ji Yeong Noh, Chae Young Lee, et al.
Virus Research (2024) Vol. 350, pp. 199471-199471
Open Access
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study
Ivan Gentile, Giulio Viceconte, F. M. Cuccurullo, et al.
Annals of Medicine (2024) Vol. 57, Iss. 1
Open Access
In silico evaluation of ten monoclonal antibodies neutralization power of SARS-CoV-2 variants EG.5, BA.2.86 and JN.1 (Preprint)
Dana Ashoor
(2024)
Closed Access
Page 1

Scroll to top